Tag Archive for: biotech

Dan Mahony & Gareth Powell – Global healthcare investing: Can hindsight hone the crystal ball for the future? A fireside chat moderated by Amy Brown, Evaluate Vantage

/in ,

Dan Mahony and Gareth Powell are long time, successful life sciences and healthcare investors. They are luminaries of the UK and European healthcare ecosystem, who have been investing since the late 1990s and initially worked together at Polar Capital where together they set up the biotech and healthcare investment funds. Gareth is still Head of […]

Read more

Synaffix Named ‘Biotech Company of the Year’ at the LSX European Lifestars Awards

/in

AMSTERDAM, THE NETHERLANDS, November 16, 2022 – Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class therapeutic index, today announces the Company has been awarded ‘Biotech Company of the Year 2022’ at the annual LSX, European Lifestars Awards Ceremony, held on the 14th of November at […]

Read more

Leading Pharma & Biotech Journalist Richard Staines Joins Optimum

/in

14 November 2022 – Optimum Strategic Communications (“Optimum”), the specialist life sciences communications consultancy, today announced that it has hired Richard Staines, the experienced, specialist pharma and biotech journalist, to join as a permanent member of its team. Staines has joined Optimum as an Account Director with immediate effect and will be advising clients across its […]

Read more

AMSilk Invited to Participate in VISION 2045 Summit

/in

Leaders from across the world will convene at VISION 2045 Summit which takes place alongside COP27 (the U.N. Climate Change Conference) in November AMSilk will be attending and participating in a panel discussion at the Vision 2045 Summit on ‘Commerce and Industry: What’s Next?’ Munich, Germany, 2 November 2022 – AMSilk GmbH (“AMSilk”), a world leader […]

Read more

Enzyre closes Series A financing round of EUR 12M to advance pioneering diagnostic technology platform for hemophilia patients

/in

Funds will be used to accelerate development of proprietary ambulant diagnostic platform and establish manufacturing capabilities Plans to expand platform beyond hemophilia A 02 November 2022, Nijmegen, Netherlands: Enzyre, which is developing breakthrough ambulant diagnostic technology for blood coagulation testing, today announced that it has successfully raised EUR 12 million in a Series A financing […]

Read more